Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men

Osteoporosis International

Volumn 11, Issue 6, 2000, Pages 481-485

  Fall, P M ^a   Kennedy, D ^a   Smith, J A ^a   Seibel, M J ^b   Raisz, L G ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bone mineral density; Bone sialoprotein; C terminal telopeptide crosslinks; N terminal telopeptide crosslinks; Osteoporosis

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN; COLLAGEN TYPE 1; ESTROGEN; SIALOPROTEIN;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; COLLAGEN METABOLISM; CROSS LINKING; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MALE; METABOLIC BONE DISEASE; OSTEOLYSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0033839651     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980070089     Document Type: Article

References (16)

1. Biochemical markers in the assessment of bone disease
2. Basic science and clinical utility of biochemical markers of bone turnover: A Congress report
3. The collagen crosslinks pyridinoline and deoxypyridinoline: A review of their biochemistry, physiology, measurement, and clinical applications
4. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption
5. Type I collagen C-telopeptide degradation products as bone resorption markers
6. Improved purification of human bone sialoprotein and development of a homologous radioimmunoassay
7. Application of a new serum assay for type I collagen cross-linked N-telopeptides: Assessment of diurnal changes in bone turnover with and without alendronate treatment
8. Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease
9. Low dose estrogen and calcium have an additive effect on bone resorption in older women
10. Clinical evaluation of the Serum Crosslaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides
11. Isoaspartyl bond formation within N-terminal sequences of collagen type I: Implications for their use as markers of collagen degradation
12. The renal clearance of free and conjugated pyridinium cross-links of collagen
13. Novel serum markers of bone resorption: Clinical assessment and comparison with established urinary indices
14. Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women
15. Bone density, bone turnover, and hormone levels in men over age 75
16. Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability